SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): April 18,
2016
Islet
Sciences, Inc.
|
|
|
|
|
001-34048
|
87-0531751
|
|
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
|
of
Incorporation)
|
|
Identification
Number)
|
|
|
|
|
|
|
1822 E
Route 66, Suite 338
Glendora,
CA 91740
|
|
|
|
|
|
|
|
|
|
|
|
866-546-3975
|
|
|
|
|
|
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
ITEM
5.02.
DEPARTURE
OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS
On
March 17, 2017, XR 22 Inc. acquired shares of the Company’s
preferred stock from ISLT in accordance with agreements between XR
22 Inc. and ISLT (the “Transaction”).
As part
of the Transaction, the following changes to the Company's
directors and officers have occurred:
●
As of March 17,
2017, Thomas Leonard was appointed as the
Company’s Chief
Executive Officer and as a member of the Company’s Board of
Directors.
●
As of March 17,
2017 John Fremont Steel IV resigned as a member of the
Company’s Board of Directors
Prior
to the Transaction, the following changes to the Company’s
directors and officers occurred:
●
Effective April
18,2016, Gary F. Blackburn, Ph.D. was appointed as a member of the
Company’s Board of Directors
●
As of September 1,
2016, Gary F. Blackburn, Ph.D. was appointed as the Company’s
President.
●
As of December 29,
2016, Matthew Carangelo was appointed as a member of the
Company’s Board of Directors.
●
As of July 26,
2016, David E. Wilder resigned as the Company’s Chief
Financial Officer.
●
As of October 31,
2016, Eugene Mannheimer resigned as a member of the Company’s
Board of Directors
As of
March 17, 2017, the Company’s Board of Directors is as
follows: Gary R. Keeling, Gary F. Blackburn, Matthew Edward
Carangelo, Thomas Leonard and Brian McFadden
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the Company has duly caused this report to be
signed on its behalf by the undersigned hereunto duly
authorized.
|
|
Islet
Sciences, Inc
|
|
|
|
|
|
|
|
|
Date: March 21,
2017
|
By:
|
/s/ Gary F.
Blackburn
|
|
|
|
|
Gary F.
Blackburn
|
|
|
|
|
President/Director
|
|